Press

Pharma Firm Eisai Moves to Prism Capital Partners’ ON3 Campus in Nutley

08/13/2020

Pharmaceutical company Eisai Inc. signed a 332,800-square-foot lease for the entirety of the former Hoffmann-La Roche headquarters building at Prism Capital Partners’ ON3 mixed-use campus in Nutley, New Jersey.

Prism Closes on Biggest NJ Lease of 2020

08/11/2020

Savills has represented pharma giant Eisai Inc. in New Jersey’s largest office lease of 2020.

Eisai Relocates U.S. Headquarters to ON3 Campus

08/11/2020

Eisai Inc., a global pharmaceutical company, will be relocating its headquarters to Prism Capital Partners‘ ON3 property, a 116-acre campus on the border of Clifton and Nutley.

Eisai to Relocate Headquarters to Nutley’s ON3 Campus

08/11/2020

Japan-based Eisai Inc., an oncology- and neurology-focused pharmaceutical company, on Tuesday said it is relocating its New Jersey-based headquarters to the ON3 campus in Nutley.

Eisai Pharmaceuticals to Make ON3 Campus Its US Headquarters

08/11/2020

Eisai Inc., an oncology- and neurology-focused pharmaceutical company and the U.S. subsidiary of Eisai Co., Ltd., (based in Tokyo) announced the relocation of its New Jersey-based headquarters to the technologically-advanced and cutting-edge ON3 property in Nutley.

Prism Inks 300,000 SF Lease at ON3 With Japanese Pharmaceutical Company

08/11/2020

Eisai, an oncology and neurology-focused pharmaceutical company, is the latest firm to call Prism’s On3 campus home.

Hackensack Meridian School of Medicine Receives Prestigious American Hospital Association Award for Community Health Work

07/31/2020

Hackensack Meridian School of Medicine is pleased to announce it has won the prestigious NOVA Award from the American Hospital Association – distinguishing it as just one of a handful of institutions across the country.

Hackensack Meridian CDI Has Struck a COVID-19 Research Collaboration With Merck

07/14/2020

The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19.

Developers Weigh New Lab, Research Projects as New Jersey Market Continues to Tighten

06/24/2020

After decades of consolidation by Big Pharma, a host of smaller, younger life sciences companies have found space at legacy research sites throughout the Garden State.

Stop Killing Our Patients: Pandemic, Protest and the Outcry for Justice

06/17/2020

Originally focused on the impact of COVID-19, the topic of conversation in these panel discussions has shifted as the pandemic has served to highlight structural inequalities in health care…

Panel on Discrimination in Time of COVID Features Dr., Alum, Oprah’s ‘Premier Role Model’

05/14/2020

“This panel, with experts who are engaged in the front-line battle against both COVID-19 and discrimination, will focus on the problems that face us – and solutions,”

Telehealth Course is ‘Part of the Future’ at Hackensack Meridian School of Medicine at SHU

05/05/2020

A dedicated telemedicine course is now taking off at Hackensack Meridian School of Medicine at Seton Hall University, aimed at educating the medical students whose curriculum has had to change due to COVID-19.

Best of 2019 – Most Unique Mixed-Use Project – Prism Capital Partners

04/09/2020

The intersection of urban vitality and suburban flexibility sits just nine miles from Manhattan at ON3.

Nutley’s Prism Capital Partners Donates Stockpile of Critical Safety Gear to Hackensack Meridian Health

03/26/2020

NUTLEY, NJ – more than 400 DuPont Tyvek Bacteria suits; more than 500 Kimtec bacterial masks; and in excess of 1,000 personal hygiene kits each containing four masks, latex gloves, a disposable thermometer, hand sanitizer and sterile wipes.were delivered to Hackensack Meridian Health’s Hackensack University Medical Center…

Hackensack Meridian Health’s COVID-19 Test Licensed for Widespread Deployment

03/25/2020

Hackensack Meridian Health announced that a rapid test for COVID-19 created by its labs at the Center for Discovery and Innovation (CDI) has been licensed to T2 Biosystems, a Massachusetts-based leader of in-vitro diagnostics.

HMH Gets Approval for Its COVID-19 Test, Immediately Puts It Into Use

03/12/2020

Hackensack Meridian Health has gotten U.S. Food & Drug Administration approval to begin using the COVID-19 test it developed in its Center for Discovery and Innovation.

Menendez Tours Lab Developing Coronavirus Test, Calls for Greater Federal Response to Combat Outbreak

02/28/2020

U.S. Senator Bob Menendez and a senior member of the Senate Finance Committee today toured the lab at Hackensack Meridian Health’s Center…

Coronavirus Test Under Development at Center for Discovery and Innovation in Nutley

02/28/2020

Researchers at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) are currently developing rapid response diagnostic tests for the coronavirus.

Nutley Moves Along with On3 Site – Building 100 Near Competition

02/18/2020

Ordinances and resolutions related to Phase IIA of the On3 site, formerly the Hoffmann-La Roche campus, were approved during the Nutley Board of Commissioners Tuesday, Feb. 4 public meeting.

Prism Capital Partners Relocates HQ to ON3 campus

02/17/2020

Prism Capital Partners announced it has relocated its headquarters to ON3, its 116-acre campus on the border of Clifton and Nutley.

HQ to ON3: Prism Capital Partners Relocates to Nutley

02/14/2020

Reflecting on a significant period of growth, Prism Capital Partners said Friday that it moved its headquarters from Bloomfield to ON3, the commercial real estate owner/operator’s 116-acre redevelopment spanning the Township of Nutley and City of Clifton.

Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium

01/17/2020

Genomic medicine’s groundbreaking treatments, and its future promise, will be the focus of a full-day symposium at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) on Wednesday, February 19.

Topology Presents Survey Findings at Nutley BOC Meeting for On3 Redevelopment Site

01/14/2020

Topology representatives Philip Abramson, founder and CEO and Christopher Colley, a development analyst gave an update on the data they collected and conclusions from the survey responses on the On3 site….

Ralph Lauren Opens Corporate Office at Nutley’s ON3 Campus

12/20/2019

Ralph Lauren formally opened its new corporate office on Prism’s ON3 campus in Nutley on Wednesday.

Ralph Lauren Opens New Corporate Office on On3 Campus in Nutley NJ

12/19/2019

NUTLEY, NJ – Ralph Lauren formally opened their new corporate office on Prism’s On3 campus Wednesday.

Nutley Commissioners Discuss On3 redevelopment site and Prism Capital Partners

12/17/2019

NUTLEY, NJ – Parks and Recreation Commissioner Mauro G. Tucci responded during the Tuesday, Dec. 3 Nutley Board of Commissioners public meeting to a post made by Mayor Joseph P. Scarpelli…

Township of Nutley Redevelopment Planner Topology Host Town Hall Meeting About On3 / Roche Project

11/17/2019

NUTLEY, NJ – Planners for the redevelopment of On3, the former Hoffmann-La Roche site, recently requested the input from Nutley residents.

On3 Developer Asks For Community Support for Marriott Hotel with Rooftop Bar on Former Roche Site in Nutley

11/15/2019

NUTLEY, NJ – Prism, the developer of the On3 project on the former Roche campus, is asking members of the community to petition the Nutley Board of Commissioners in support of the new Marriott AC hotel with rooftop bar.

ON3 Campus: Developer Replaces 14 Stories of Marble for Clear Views of NYC

10/14/2019

NUTLEY — As the Route 3 campus that was once home to pharmaceutical giant Hoffmann-La Roche fills up with new structures and tenants, some of the older buildings are undergoing makeovers to get some of the attention.

More Than 1,000 Ralph Lauren Employees Begin to Move Into ON3 Campus Building in Nutley

10/10/2019

NUTLEY — Workers in hard hats were still putting the finishing touches on Ralph Lauren’s new Route 3 digs this week.

Construction Hitting Milestones at Prism’s ON3

09/16/2019

ON3, 116-acre campus in Clifton and Nutley, has hit the ground running this summer with several key projects at the mid-way point or near completion, according to developer Prism Capital Partners.

Work Hitting ‘High Gear’ At Former Roche Site In Nutley, Clifton

09/16/2019

Major work is almost done at the future home of Ralph Lauren, developers said.

Hackensack Meridian Health Opens Center for Discovery and Innovation to Support Groundbreaking Research

05/30/2019

New center will focus on research for cancer, infectious disease and regenerative medicine and create hundreds of scientific jobs in North Jersey

Prism Capital Partners Retains Architect at Hoffmann-LaRoche Campus in Nutley

05/07/2019

Chicago-based Goettsch Partners — the architectural firm behind the redevelopment of Chicago Union Station — has been retained by Prism Capital Partners to design a pair of Class A towers comprising 400,000 square feet of office space at the former Hoffmann-La Roche campus in Clifton and Nutley.

OFFICE
  • 100 Metro Blvd

  • 200 Metro Blvd

CAMPUS
ABOUT

© 2019 ON3. All Rights Reserved. Website by MTG.